Episode
Direct Clinical Trial Management: Practical Approaches to CRO Selection and Clinical Outsourcing for Lean Biotech Teams with Antonio Bermejo Gomez
- Published
- Jun 2, 2026
- Duration seconds
- 1721
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-cog-review-building-better-clinical-studies-7614513/episodes/direct-clinical-trial-management-practical-approaches-to-cro-selection-and-clinical-outsourcing-for-lean-biotech-teams-with-antonio-bermejo-gomez/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-cog-review-building-better-clinical-studies-7614513/direct-clinical-trial-management-practical-approaches-to-cro-selection-and-clinical-outsourcing-for-lean-biotech-teams-with-antonio-bermejo-gomez.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Unlock best practices for sponsor-led decision-making in clinical trial outsourcing, with real-world insight into optimizing CRO selection, partnership models, and operational efficiency, straight from a lean biotech team navigating these choices under budget and time constraints. Guest Antonio Bermejo Gomez, Chief Development Officer, Synartro Operational leader at a Swedish clinical-stage biotech, hands-on with direct sponsor oversight, CRO/vendor selection, and clinical trial delivery LinkedIn: Antonio Bermejo Gomez Moderator: Sverre Bengtsson, Clinical Trials Advisor Episode Overview Recorded live at COG Nordics, this focused session features Antonio Bermejo Gomez, Chief Development Officer at Synartro, sharing a sponsor’s perspective on direct clinical trial management. The discussion, guided by David Jones and Sverre Bengtsson, centers on how very small biotech organizations can retain control, make more agile decisions, and achieve clinical study optimization even with limited team size and resources. This episode addresses the core of clinical trial outsourcing: how to maximize operational efficiency, preserve sponsor accountability, and adapt CRO selection frameworks for niche or highly constrained environments. Antonio Bermejo Gomez breaks down real-world strategies for working with specialized consultants, defining sponsor versus CRO responsibilities, and ensuring transparent decision ownership throughout a trial’s lifecycle. Listeners will hear practical insights on: Structuring lean teams to optimize clinical operations without traditional full-service CRO partnerships Balancing the roles of independent consultants, vendor partners, and in-house expertise Critical considerations in CRO and CDMO selection when project fit and operational transparency are bu…